Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies

European Journal of Cancer

Volumn 48, Issue 16, 2012, Pages 3045-3051

  Du Four, Stephanie ^a   Wilgenhof, Sofie ^a   Duerinck, Johnny ^a   Michotte, Alex ^a   Binst, Anne Van ^a   Ridder, Mark De ^a   Neyns, Bart ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Brain metastasis; Ipilimumab; Melanoma; Radiation necrosis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DACARBAZINE; DENDRITIC CELL VACCINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IPILIMUMAB; METHYLPREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; SUNITINIB;

ADJUVANT THERAPY; ADRENAL METASTASIS; ADULT; APRAXIA; ARTICLE; AXILLARY LYMPH NODE; BALANCE DISORDER; BRAIN EDEMA; BRAIN METASTASIS; BRAIN NECROSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CASE REPORT; COLITIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFUSION; COORDINATION DISORDER; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DYSPHASIA; FEMALE; FOLLOW UP; FOREARM; GAIT DISORDER; GLIOSIS; HEADACHE; HUMAN; INDUCTION CHEMOTHERAPY; LIMB DYSESTHESIA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; MOTOR COORDINATION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAAORTIC LYMPH NODE; PARAVENTRICULAR THALAMIC NUCLEUS; PARIETAL LOBE; PARIETO-OCCIPITAL SULCUS; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION NECROSIS; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; SALVAGE THERAPY; SEIZURE; SKIN METASTASIS; STEREOTACTIC RADIOSURGERY;

ADULT; ANTIBODIES, MONOCLONAL; BIOPSY; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; NECROSIS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84867580941     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.05.016     Document Type: Article

References (23)

1. D. Bafaloukos, and H. Gogas The treatment of brain metastases in melanoma patients Cancer Treat Rev 30 6 2004 515 520
2. F.S. Hodi, D.a. Oble, and J. Drappatz CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS Nat Oncol 5 9 2008 557 561
3. A.E. Sloan, C.J. Nock, and D.B. Einstein Diagnosis and treatment of melanoma brain metastasis: a literature review Cancer Control 16 3 2009 248 255
4. N. Schartz, C. Farges, and I. Madelaine Complete regression of a previously untreated melanoma brain metastasis with ipilimumab Melanoma Res 20 3 2010 247 250
5. W. Boogerd, G.C. de Gast, and O. Dalesio Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation? Cancer 109 2 2007 306 312
6. P.M. Patel, S. Suciu, and L. Mortier Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032) Eur J Cancer 47 10 2011 1476 1483
7. V. Chiarion-Sileni, M. Guida, and L. Ridolfi Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens Br J Cancer 104 12 2011 1816 1821
8. F.S. Hodi, S.J. O'Day, and D.F. McDermott Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 363 8 2010 711 723
9. J.D. Wolchok, B. Neyns, and G. Linette Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study Lancet Oncol 11 2 2010 155 164
10. D.P. Lawrence, O. Hamid, and D.F. McDermott Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastases ASCO Meeting Abstr 28 2010 8523
11. K.a. Margolin, A.M. DiGiacomo, and M. Maio Brain metastasis in melanoma: clinical activity of CTLA-4 antibody therapy Semin Oncol 37 5 2010 468 472
12. K. Margolin, M.S. Ernstoff, and O. Hamid Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial Lancet Oncol 2045 12 2012 1 7
13. J.J. Hong, S.a. Rosenberg, and M.E. Dudley Successful treatment of melanoma brain metastases with adoptive cell therapy Clin Cancer Res 16 19 2010 4892 4898
14. L. Decoster, B. Neyns, I. Vanden Broek, and J. De Grève Activity of Sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers ASCO Meeting Abstr 28 2010 8518
15. B. Neyns, S. Wilgenhof, and A.M.T. Van Nuffel A phase I clinical trial on the combined intravenous (IV) and intradermal (ID) administration of autologous TriMix-DC cellular therapy in patients with pretreated melanoma (TriMixIDIV) ASCO Meeting Abstr 29 2011 2519
16. G. Minniti, E. Clarke, and G. Lanzetta Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis Radiat Oncol 6 2011 48
17. C. Matuschek, E. Bölke, and J. Nawatny Bevacizumab as a treatment option for radiation-induced cerebral necrosis Strahlenther Onkol 187 2 2011 135 139
18. C.M. McPherson, and R.E. Warnick Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging J Neurooncol 68 1 2004 41 47
19. J. Weber Ipilimumab: controversies in its development, utility and autoimmune adverse events Cancer Immunol Immunother 58 5 2009 823 830
20. S. Wilgenhof, and B. Neyns Anti-CTLA-4 antibody induced Guillain Barré syndrome in a melanoma patient Ann Oncol 22 2011 991 993
21. M. Kocher, R. Soffietti, and U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 Study Clin Oncol 29 2 2011 134 141
22. M. Tsao, W. Xu, and A. Sahgal A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases Cancer 118 9 2012 2486 2493
23. E.L. Chang, J.S. Wefel, and K.R. Hess Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial Lancet Oncol 10 11 2009 1037 1044